Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol in Parkinson Disease
NCT02941822Phase 2Completed
- Sponsor
- University College London
- Start
- Dec 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambroxol in Parkinson's disease (PD), sponsored by University College London. Started Dec 2016; status: completed.
02
Drugs
ambroxol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02941822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941822.